CTOs on the Move

Amplyx Pharmaceuticals

www.amplyx.com

 
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The resulting, new therapeutic creates a more targeted molecule with the goal of improving treatment outcomes and improving compliance with treatment regimens. Our initial development areas are in oncology and infectious disease.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.amplyx.com
  • 3210 Merryfield Row
    San Diego, CA USA 92121-1126
  • Phone: 415.578.3263

Executives

Name Title Contact Details

Funding

Amplyx Pharmaceuticals raised $40.5M on 11/11/2015
Amplyx Pharmaceuticals raised $53M on 05/19/2020

Similar Companies

Detroit Wayne Mental Health Authority

DWIHN provides support to children with serious emotional disturbance, people with mental illness, developmental disability and/or substance use disorder.

Cedarburg Hauser Pharmaceuticals

Cedarburg Hauser Pharmaceuticals is a Grafton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aeon Biopharma

Aeon Biopharma is leading the way as the first and only company focused solely on toxins for therapeutic applications. We are innovating toxin use to improve the lives of patients who are suffering from debilitating medical disorders. AEON is excited to introduce ABP450, the first 900 kDa toxin innovation in the US for over 30 years, and is proud to partner with physicians to advance treatment options. We are dedicated to enhancing patient lives by leading in new ways to use toxins while improving existing toxin therapy.

Avitus Orthopaedics

Avitus Orthopaedics is a medical device company developing novel surgical instruments for minimally invasive tissue harvesting. Empower your fusions.

Aspen Pharmacare Canada

We have a proud heritage dating back more than 160 years and is committed to sustaining life and promoting healthcare through increasing access to our high quality, affordable medicines and products. As a leading global player in specialty, branded and generic pharmaceuticals, we have an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. We continue to increase the number of lives benefiting from our products that reach more than 150 countries. In line with the our commercial, production and territorial strategies, we have identified Thrombosis, Anaesthetics, High Potency & Cytotoxics as our focused therapeutic categories that will receive our highest focus based on materiality and future potential.